GlassScriptPhysician profile
Janeth M Yinh
NPI 1316956451
$5,995.01
in general payments reported to CMS, 2019-2025
5 companies · $3,557 in 2025
The $3,557 reported for 2025 was more than what 81% of Rheumatology providers received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $99.00 · 2023: $2,040 · 2024: $298 · 2025: $3,557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,520 · Food and Beverage: $976 · Education: $355 · Travel and Lodging: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,520.00 |
| Food and Beverage | $976.05 |
| Education | $354.96 |
| Travel and Lodging | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $5,289.78 | 2022-2025 | Tremfya, Stelara |
| Astrazeneca Pharmaceuticals LP | $327.33 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $160.00 | 2023-2024 | |
| Horizon Therapeutics Plc | $113.86 | 2023 | Krystexxa |
| Ucb, INC. | $104.04 | 2025 | Bimzelx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janeth Yinh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.